104 related articles for article (PubMed ID: 21165772)
1. Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice.
Gorczynski RM; Clark DA; Erin N; Khatri I
Breast Cancer Res Treat; 2011 Nov; 130(1):49-60. PubMed ID: 21165772
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6.
Podnos A; Clark DA; Erin N; Yu K; Gorczynski RM
Breast Cancer Res Treat; 2012 Nov; 136(1):117-27. PubMed ID: 23053647
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice.
Gorczynski RM; Chen Z; Diao J; Khatri I; Wong K; Yu K; Behnke J
Breast Cancer Res Treat; 2010 Sep; 123(2):405-15. PubMed ID: 19953316
[TBL] [Abstract][Full Text] [Related]
4. Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.
Curry A; Khatri I; Kos O; Zhu F; Gorczynski R
PLoS One; 2017; 12(2):e0171586. PubMed ID: 28234914
[TBL] [Abstract][Full Text] [Related]
5. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
Yu K; Chen Z; Gorczynski R
Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
[TBL] [Abstract][Full Text] [Related]
8. CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients.
Yu K; Chen Z; Khatri I; Gorczynski RM
Immunol Lett; 2011 Dec; 141(1):116-22. PubMed ID: 21945175
[TBL] [Abstract][Full Text] [Related]
9. Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3(+)Treg and mast cells.
Gorczynski RM; Chen Z; Khatri I; Yu K
Transpl Immunol; 2011 Dec; 25(4):187-93. PubMed ID: 21801836
[TBL] [Abstract][Full Text] [Related]
10. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.
Rygiel TP; Karnam G; Goverse G; van der Marel AP; Greuter MJ; van Schaarenburg RA; Visser WF; Brenkman AB; Molenaar R; Hoek RM; Mebius RE; Meyaard L
Oncogene; 2012 Jun; 31(24):2979-88. PubMed ID: 22020332
[TBL] [Abstract][Full Text] [Related]
11. Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.
Gorczynski RM; Chen Z; Khatri I; Podnos A; Yu K
Breast Cancer Res Treat; 2013 Nov; 142(2):271-82. PubMed ID: 24166280
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
Gorczynski RM; Erin N; Maqbool T; Gorczynski CP; Gorczynski LY
Breast Cancer; 2018 Sep; 25(5):547-559. PubMed ID: 29532324
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-β abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice.
Gorczynski R; Yu K; Chen Z
Transplantation; 2014 Jan; 97(1):39-46. PubMed ID: 24142033
[TBL] [Abstract][Full Text] [Related]
14. Persistence of gene expression profile in CD200 transgenic skin allografts is associated with graft survival on retransplantation to normal recipients.
Yu K; Gorczynski RM
Transplantation; 2012 Jul; 94(1):36-42. PubMed ID: 22683854
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
[TBL] [Abstract][Full Text] [Related]
16. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
[TBL] [Abstract][Full Text] [Related]
17. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
Zhong Z; Carroll KD; Policarpio D; Osborn C; Gregory M; Bassi R; Jimenez X; Prewett M; Liebisch G; Persaud K; Burtrum D; Wang S; Surguladze D; Ng S; Griffith H; Balderes P; Doody J; Schwartz JD; Youssoufian H; Rowinsky EK; Ludwig DL; Witte L; Zhu Z; Wu Y
Clin Cancer Res; 2010 Feb; 16(4):1191-205. PubMed ID: 20145179
[TBL] [Abstract][Full Text] [Related]
18. Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
Cho HM; Rosenblatt JD; Tolba K; Shin SJ; Shin DS; Calfa C; Zhang Y; Shin SU
Cancer Res; 2010 Dec; 70(24):10121-30. PubMed ID: 21159634
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
Clark DA; Gorczynski RM; Blajchman MA
Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
[TBL] [Abstract][Full Text] [Related]
20. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
